Emmaus Medical, Inc.
$197.9K 389 recipients
Compare payment profiles
CMS Open Payments · Program Year 2024
Pfizer International LLC
Pfizer International LLC reported $197,488.44 across General Payments, Research, and Ownership to 69 physicians and teaching hospitals across 69 transactions.
- $197.5K Below-median payer
- All-tracks total
- 69 Below-median volume
- Transactions
- 69 Below-median reach
- Recipients
- +$88.5K
- General Payments vs PY2023
Pfizer International LLC reported $197,488.44 across all CMS Open Payments tracks (General + Research + Ownership) to 69 physicians and teaching hospitals in Program Year 2024 - ranking #1003 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $197,488.44, averaging $2.9K per recipient.
How Pfizer International LLC's $197.5K all-tracks total breaks down
Pfizer International LLC's payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
F
21/100
Total payments
F
12/100
Transaction volume
F
10/100
Physician reach
F
10/100
Payment type diversity
D
50/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer pfizer-international-llc Pfizer International LLC
$197.5K · #1003/1,925 · 0.0% industry · PY2024
- TOT $197.5K
- RANK #1003
- SHARE 0.0%
- TXN 69
- RCP 69
- CAT 4
- GEN $197.5K
- ΔGEN +$88.5K
- TOP1 29.6%
- PY 2024
Volume peers
Nearest volume peer: Emmaus Medical, Inc. ($197.9K)
Pfizer International LLC sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
Pfizer International LLC's CMS-reported General Payments increased by $88.5K (+81.2%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2022: PFIZER INTERNATIONAL LLCPY2023: PFIZER INTERNATIONAL LLCPY2024: PFIZER INTERNATIONAL LLC. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $108,976.76
- PY2024
- $197,488.44
What the Data Shows for Pfizer International LLC
CMS Open Payments is not a single ledger: the all-tracks total shown above is General Payments plus Research Payments plus Ownership/Investment interests, each with its own disclosure rules. For Pfizer International LLC, that total blends General Payments (day-to-day consulting, meals, travel and speaking fees, shown separately above) with Research and Ownership/Investment interest records, each governed by its own CMS reporting rules. Data for a given Program Year arrives roughly a year after the period it covers; our methodology page documents the release cadence and how we standardize the tracks for cross-company comparison.
Of the 4 general-payment categories charted below, "Compensation for Services Other Than Consulting" is the largest at $107.0K across 17 transactions, 54.2% of this company's General Payments (see our methodology for how research and ownership payments are reported separately).
General Payment Breakdown by Type
"Compensation for Services Other Than Consulting" leads Pfizer International LLC's 4-category general-payment breakdown at $107.0K, 54.2% of the reported total.
Pfizer International LLC reports 4 general-payment categories - the top three are Compensation for Services Other Than Consulting (54.2%), Travel and Lodging (31.0%), and Consulting Fee (14.0%). The remaining 1 category make up 0.8% of this company's reported general-payment total. That multi-category mix is the kind of profile single-category reporters cannot show.
How Pfizer International LLC divides its payments
How the reported total splits across payment categories
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Compensation for Services Other Than Consulting | $107.0K | 17 | 54.2% |
| Travel and Lodging | $61.3K | 45 | 31.0% |
| Consulting Fee | $27.7K | 2 | 14.0% |
| Food and Beverage | $1.5K | 5 | 0.8% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $154,614.42 (78.3%) of $197,488.44 in this company's General Payments records across 19 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Pfizer International LLC
The five named recipients with the highest reported General Payments from this company
- 1
Julio Ramirez
$58,442.04 across 13 reported transactions
- 2
Maria Mejias
$43,646.86 across 10 reported transactions
- 3
Stephen Thomas
$32,447.76 across 10 reported transactions
- 4
Cesia Gallegos Kattan
$11,081.24 across 2 reported transactions
- 5
Lawrence Silverman
$8,996.52 across 5 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
Pfizer International LLC's spend rank (#1003 of 1,925, bottom 48% by spend) and concentration rank (#801 of 1,838, top 44% most concentrated) land at roughly the same percentile, an unusually proportionate case where payment size and payment concentration move together.
View all 12 companies in this HHI neighborhood as a list
- Citieffe, Inc. : $145.4K total payments, HHI 1775
- Diagnostica Stago, Inc : $49.4K total payments, HHI 1775
- Cerus Corporation : $405.7K total payments, HHI 1771
- Brixton Biosciences, Inc. : $36.4K total payments, HHI 1756
- Sysmex America, Inc. : $54.4K total payments, HHI 1755
- bluebird bio, Inc. : $208.3K total payments, HHI 1750
- Pfizer International LLC (this company) : $197.5K total payments, HHI 1747
- NextStep Arthropedix, LLC : $125.7K total payments, HHI 1747
- Greiner Bio-One North America, Inc. : $11.6K total payments, HHI 1746
- CashFlow Solutions, LLC : $89.2K total payments, HHI 1745
- Acumed LLC : $3.4M total payments, HHI 1742
- Thermo Fisher Scientific Asheville LLC : $2.2K total payments, HHI 1739
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Pfizer International LLC's, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Pfizer International LLC.
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Pfizer International LLC.
Showing 6 of 1,924 companies with CMS-reported payment data.
Noven Therapeutics, LLC
$197.9K 11,053 recipients
Compare payment profiles
Acuity Surgical Devices, LLC
$196.1K 110 recipients
Compare payment profiles
CurvaFix, Inc.
$196.0K 135 recipients
Compare payment profiles
Applied Medical Technology Inc
$199.2K 132 recipients
Compare payment profiles
ulrich medical USA, Inc.
$199.2K 97 recipients
Compare payment profiles
Put this to use
Pfizer International LLC ranks #1003 of 1,925 by all-tracks total payments, led by "Compensation for Services Other Than Consulting".
- See how manufacturer spending compares across the full leaderboard. Top 100 by total payments
- Compare "Compensation for Services Other Than Consulting" spend across every manufacturer, not just Pfizer International LLC. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.